Structured Summary
Abstract
An interferon beta-1 subtype that has a methionine at position 1, a cysteine at position 17, and is glycosylated at position 80. It functions as an ANTI-VIRAL AGENT and IMMUNOMODULATOR and is used to manage the symptoms of RELAPSING-REMITTING MULTIPLE SCLEROSIS.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
6 entry terms
- Interferon beta 1a
- beta 1a, Interferon
- beta-1a, Interferon
- Avonex
- Avonex Pen
- Rebif
MeSH Record
Aspects Covered
30 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2016 (1994)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Interferon beta-1a. Medical Subject Headings (MeSH). 2026. Unique ID D000068556. http://id.nlm.nih.gov/mesh/2026/D000068556
- Interferon beta-1a. In: Wikipedia. https://en.wikipedia.org/wiki/Interferon_beta-1a
- Interferon beta-1a. In: Wikidata. https://www.wikidata.org/wiki/Q2450337